Regulon

Regulon: R-1969

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
13-1.0599910Pr-136Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3735 ENSG00000065427 KARS Q15046
79796 ENSG00000086848 ALG9 Q9H6U8
10419 ENSG00000100462 PRMT5 O14744
1477 ENSG00000101138 CSTF1 Q05048
5717 ENSG00000108671 PSMD11 O00231
28960 ENSG00000110063 DCPS Q96C86
2976 ENSG00000115207 GTF3C2 Q8WUA4
25926 ENSG00000130935 NOL11 Q9H8H0
10989 ENSG00000132305 IMMT Q16891
51542 ENSG00000143952 VPS54 Q9P1Q0
6240 ENSG00000167325 RRM1 P23921
246243 ENSG00000171865 RNASEH1 O60930
9943 ENSG00000172939 OXSR1 O95747

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
OPROZOMIBPSMD1Small moleculeINHIBITOR26S proteosome inhibitor10
IXAZOMIBPSMD1Small moleculeINHIBITOR26S proteasome inhibitor40
CLOFARABINEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor40
GALLIUM NITRATERRM1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor40
GEMCITABINE HYDROCHLORIDERRM1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
HYDROXYUREARRM1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor43
BORTEZOMIBPSMD1Small moleculeINHIBITOR26S proteosome inhibitor41
GEMCITABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
IXAZOMIB CITRATEPSMD1Small moleculeINHIBITOR26S proteosome inhibitor40
TEZACITABINERRM1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor20
TRIAPINERRM1Small moleculeINHIBITORRibonucleotide reductase inhibitor30
FLUDARABINE PHOSPHATEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor41
MOTEXAFIN GADOLINIUMRRM1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor31
CARFILZOMIBPSMD1ProteinINHIBITOR26S proteosome inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1969

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs